Magnesium salicylate
Description
Type: small molecule
Groups: approved
Indication: Magnesium salicylate is a common analgesic and non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate muscular pain
Accession Number: DB01397 ( DB01397)
Description: Magnesium salicylate is a common analgesic and non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate muscular pain. It is also used to treat headaches, general back pain, and certain joint pains like arthritis. It is found in a variety of over-the-counter (OTC) medications as an anti-inflammatory, primarily for back-pain relief. Magnesium Salicylate can be an effective OTC alternative to prescription NSAIDs, with both anti-inflamatory and pain-relieving effects. Though the recommended doseage is 1160 mg every six hours, per package directions of the Doan's OTC brand (580 mg magnesium salicylate tetrahydrate, equivalent to 934.4 mg anhydrous magnesium salicylate), effective pain relief is often found with a half dosage, with reduced anti-inflammatory results.
Structure:
Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Back Relief | tablet | Array | oral | 14-05-2013 | US | |
Back-ese M Tab 325mg | tablet | 325 mg | Array | 31-12-1985 | 25-06-1998 | Canada |
Diurex Water Pills | tablet, coated | Array | oral | 15-05-2005 | US | |
Medique Back Pain Off | tablet, film coated | Array | oral | 30-12-2008 | US | |
Otis Clapp Back Quell | tablet, film coated | Array | oral | 30-12-2008 | US | |
Pain Aid Brf | tablet | Array | oral | 19-08-2012 | US | |
Pamprin Cramp Menstrual Pain Relief | tablet | Array | oral | 01-01-1983 | US | |
Vica-cet | tablet | Array | oral | 03-04-2015 | US |
Generic Prescription Products: Not Available
Over the Counter Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Arthriten Tablets | tablet | 325 mg | oral | 15-05-2003 | 27-07-2006 | Canada |
Back-ese M Tablets 325 mg | tablet | 325 mg | oral | 31-12-1980 | 19-07-2000 | Canada |
Backache Aid | tablet, film coated | 580 mg/1 | oral | 07-11-1998 | US | |
Backache Relief | tablet, film coated | 580 mg/1 | oral | 07-11-1998 | US | |
Backache Relief | tablet, film coated | 580 mg/1 | oral | 07-11-1998 | US | |
Backache Relief Extra Strength | tablet | 580 mg/1 | oral | 07-11-1998 | US | |
Backache Relief Extra Strength | tablet, film coated | 580 mg/1 | oral | 07-11-1998 | US | |
Doan's Backache Pills 325mg | tablet | 325 mg | oral | 31-12-1988 | 08-07-1998 | Canada |
Doans Extra Strength | tablet | 580 mg/1 | oral | 15-05-2013 | US | |
Extra Strength Backache Relief | capsule | 580 mg/1 | oral | 07-11-1998 | US | |
Herbogesic | tablet | 650 mg | oral | 31-12-1988 | 06-07-2009 | Canada |
Kneerelief Tablets | tablet | 650 mg | oral | 15-05-2003 | 27-07-2006 | Canada |
Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Back Relief | tablet | Array | oral | 14-05-2013 | US | |
Back-ese M Tab 325mg | tablet | 325 mg | Array | 31-12-1985 | 25-06-1998 | Canada |
Diurex Water Pills | tablet, coated | Array | oral | 15-05-2005 | US | |
Medique Back Pain Off | tablet, film coated | Array | oral | 30-12-2008 | US | |
Otis Clapp Back Quell | tablet, film coated | Array | oral | 30-12-2008 | US | |
Pain Aid Brf | tablet | Array | oral | 19-08-2012 | US | |
Pamprin Cramp Menstrual Pain Relief | tablet | Array | oral | 01-01-1983 | US | |
Vica-cet | tablet | Array | oral | 03-04-2015 | US |
Over the Counter Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Arthriten Tablets | tablet | 325 mg | oral | 15-05-2003 | 27-07-2006 | Canada |
Back-ese M Tablets 325 mg | tablet | 325 mg | oral | 31-12-1980 | 19-07-2000 | Canada |
Backache Aid | tablet, film coated | 580 mg/1 | oral | 07-11-1998 | US | |
Backache Relief | tablet, film coated | 580 mg/1 | oral | 07-11-1998 | US | |
Backache Relief | tablet, film coated | 580 mg/1 | oral | 07-11-1998 | US | |
Backache Relief Extra Strength | tablet | 580 mg/1 | oral | 07-11-1998 | US | |
Backache Relief Extra Strength | tablet, film coated | 580 mg/1 | oral | 07-11-1998 | US | |
Doan's Backache Pills 325mg | tablet | 325 mg | oral | 31-12-1988 | 08-07-1998 | Canada |
Doans Extra Strength | tablet | 580 mg/1 | oral | 15-05-2013 | US | |
Extra Strength Backache Relief | capsule | 580 mg/1 | oral | 07-11-1998 | US | |
Herbogesic | tablet | 650 mg | oral | 31-12-1988 | 06-07-2009 | Canada |
Kneerelief Tablets | tablet | 650 mg | oral | 15-05-2003 | 27-07-2006 | Canada |
International Brands
- No Brands
Brand Names
- No Brands
Brand Mixtures
Brand Name | Ingredients |
---|---|
Backache Relief Extra Strength | Magnesium salicylate |
Back Relief | Acetaminophen + Magnesium salicylate |
Backache Relief | Magnesium salicylate |
Pain Aid Brf | Magnesium salicylate + Acetaminophen |
Pamprin Cramp Menstrual Pain Relief | Acetaminophen + Magnesium salicylate + Pamabrom |
Medique Back Pain Off | Magnesium salicylate + Caffeine + Acetaminophen |
Otis Clapp Back Quell | Magnesium salicylate + Acetaminophen |
Backache Relief Extra Strength | Magnesium salicylate |
Diurex Water Pills | Magnesium salicylate + Caffeine |
Extra Strength Backache Relief | Magnesium salicylate |
Doans Extra Strength | Magnesium salicylate |
Backache Relief | Magnesium salicylate |
Vica-cet | Magnesium salicylate + Acetaminophen |
Back-ese M Tablets 325 mg | Magnesium salicylate |
Back-ese M Tab 325mg | Magnesium salicylate |
Arthriten Tablets | Magnesium salicylate |
Kneerelief Tablets | Magnesium salicylate |
Doan's Backache Pills 325mg | Magnesium salicylate |
Herbogesic | Magnesium salicylate |
Backache Aid | Magnesium salicylate |
Brand Name | Ingredients |
---|---|
Backache Relief Extra Strength | Magnesium salicylate |
Back Relief | Acetaminophen + Magnesium salicylate |
Backache Relief | Magnesium salicylate |
Pain Aid Brf | Magnesium salicylate + Acetaminophen |
Pamprin Cramp Menstrual Pain Relief | Acetaminophen + Magnesium salicylate + Pamabrom |
Medique Back Pain Off | Magnesium salicylate + Caffeine + Acetaminophen |
Otis Clapp Back Quell | Magnesium salicylate + Acetaminophen |
Backache Relief Extra Strength | Magnesium salicylate |
Diurex Water Pills | Magnesium salicylate + Caffeine |
Extra Strength Backache Relief | Magnesium salicylate |
Doans Extra Strength | Magnesium salicylate |
Backache Relief | Magnesium salicylate |
Vica-cet | Magnesium salicylate + Acetaminophen |
Back-ese M Tablets 325 mg | Magnesium salicylate |
Back-ese M Tab 325mg | Magnesium salicylate |
Arthriten Tablets | Magnesium salicylate |
Kneerelief Tablets | Magnesium salicylate |
Doan's Backache Pills 325mg | Magnesium salicylate |
Herbogesic | Magnesium salicylate |
Backache Aid | Magnesium salicylate |
Categories
- No Category
Pharmacology
Pharmacodynamics: Not Available
Mechanism of action: Most NSAIDs act as nonselective inhibitors of the enzyme cyclooxygenase (COX), inhibiting both the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) isoenzymes. COX catalyzes the formation of prostaglandins and thromboxane from arachidonic acid (itself derived from the cellular phospholipid bilayer by phospholipase A2). Prostaglandins act (among other things) as messenger molecules in the process of inflammation.
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half life: Not Available
Clearance: Not Available
Toxicity: Not Available
Affected organisms
- Not Available
SNP Mediated Adverse Drug Reactions
- Not Available
Pharmacoeconomics
- Not Available
Packagers:
- Caraco Pharmaceutical Labs
- CVS Pharmacy
- Ivax Pharmaceuticals
- Key Co.
- Novartis AG
- Palmetto Pharmaceuticals Inc.
- Qualitest
- US Pharmaceutical Corp.
Dosage forms
Form | Route | Strength |
---|---|---|
Tablet | oral | |
Tablet | 325 mg | |
Tablet | oral | 325 mg |
Tablet, film coated | oral | 580 mg/1 |
Tablet | oral | 580 mg/1 |
Tablet, coated | oral | |
Capsule | oral | 580 mg/1 |
Tablet | oral | 650 mg |
Tablet, film coated | oral |
Form | Route | Strength |
---|---|---|
Tablet | oral | |
Tablet | 325 mg | |
Tablet | oral | 325 mg |
Tablet, film coated | oral | 580 mg/1 |
Tablet | oral | 580 mg/1 |
Tablet, coated | oral | |
Capsule | oral | 580 mg/1 |
Tablet | oral | 650 mg |
Tablet, film coated | oral |
Prices
Unit description | Cost | Unit |
---|---|---|
Choline mag trisal 1 gm tablet | $1.15 | tablet |
Tricosal 1000 mg tablet | $1.23 | tablet |
Keygesic-10 650 mg tablet | $0.05 | tablet |
CVS Pharmacy backache rlf 580 mg caplet | $0.18 | caplet |
Doan's regular 325 mg tablet | $0.18 | tablet |
Doan's ex strength 580 mg tablet | $0.22 | tablet |
Choline mag trisal 500 mg tablet | $0.64 | tablet |
Novasal 600 mg tablet | $0.75 | tablet |
Choline mag trisal 750 mg tablet | $0.81 | tablet |
Unit description | Cost | Unit |
---|---|---|
Choline mag trisal 1 gm tablet | $1.15 | tablet |
Tricosal 1000 mg tablet | $1.23 | tablet |
Keygesic-10 650 mg tablet | $0.05 | tablet |
CVS Pharmacy backache rlf 580 mg caplet | $0.18 | caplet |
Doan's regular 325 mg tablet | $0.18 | tablet |
Doan's ex strength 580 mg tablet | $0.22 | tablet |
Choline mag trisal 500 mg tablet | $0.64 | tablet |
Novasal 600 mg tablet | $0.75 | tablet |
Choline mag trisal 750 mg tablet | $0.81 | tablet |
Patents
Country | Patent Number | Approved | Expires (estimated) |
---|
Interactions
Drug | Interaction |
---|---|
Abciximab | Magnesium salicylate may increase the anticoagulant activities of Abciximab. |
Acenocoumarol | Magnesium salicylate may increase the anticoagulant activities of Acenocoumarol. |
Acetazolamide | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Acetazolamide. |
Acetylsalicylic acid | Acetylsalicylic acid may increase the anticoagulant activities of Magnesium salicylate. |
Alfacalcidol | The serum concentration of Magnesium salicylate can be increased when it is combined with Alfacalcidol. |
Alteplase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Alteplase. |
Amlodipine | The risk or severity of adverse effects can be increased when Amlodipine is combined with Magnesium salicylate. |
Ammonium chloride | The serum concentration of Magnesium salicylate can be increased when it is combined with Ammonium chloride. |
Amrinone | The risk or severity of adverse effects can be increased when Amrinone is combined with Magnesium salicylate. |
Anistreplase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Anistreplase. |
Bepridil | The risk or severity of adverse effects can be increased when Bepridil is combined with Magnesium salicylate. |
Calcitriol | The serum concentration of Magnesium salicylate can be increased when it is combined with Calcitriol. |
Citric Acid | Magnesium salicylate may increase the anticoagulant activities of Citric Acid. |
Dalteparin | Magnesium salicylate may increase the anticoagulant activities of Dalteparin. |
Deferiprone | The serum concentration of Deferiprone can be decreased when it is combined with Magnesium salicylate. |
Desmopressin | The risk or severity of adverse effects can be increased when Desmopressin is combined with Magnesium salicylate. |
Dexketoprofen | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Dexketoprofen. |
Diclofenamide | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Diclofenamide. |
Dicoumarol | Magnesium salicylate may increase the anticoagulant activities of Dicoumarol. |
Dolutegravir | The serum concentration of Dolutegravir can be decreased when it is combined with Magnesium salicylate. |
Edetic Acid | Magnesium salicylate may increase the anticoagulant activities of Edetic Acid. |
Eltrombopag | The serum concentration of Eltrombopag can be decreased when it is combined with Magnesium salicylate. |
Enoxaparin | Magnesium salicylate may increase the anticoagulant activities of Enoxaparin. |
Ethoxzolamide | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Ethoxzolamide. |
Ethyl biscoumacetate | Magnesium salicylate may increase the anticoagulant activities of Ethyl biscoumacetate. |
Felodipine | The risk or severity of adverse effects can be increased when Felodipine is combined with Magnesium salicylate. |
Fludrocortisone | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Fludrocortisone. |
Flunarizine | The risk or severity of adverse effects can be increased when Flunarizine is combined with Magnesium salicylate. |
Fondaparinux sodium | Magnesium salicylate may increase the anticoagulant activities of Fondaparinux sodium. |
Gabapentin | Magnesium salicylate may increase the central nervous system depressant (CNS depressant) activities of Gabapentin. |
Ginkgo biloba | Ginkgo biloba may increase the anticoagulant activities of Magnesium salicylate. |
Heparin | Magnesium salicylate may increase the anticoagulant activities of Heparin. |
Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Magnesium salicylate. |
Insulin Regular | Magnesium salicylate may increase the hypoglycemic activities of Insulin Regular. |
Isradipine | The risk or severity of adverse effects can be increased when Isradipine is combined with Magnesium salicylate. |
Lamotrigine | The risk or severity of adverse effects can be increased when Lamotrigine is combined with Magnesium salicylate. |
Lercanidipine | The risk or severity of adverse effects can be increased when Lercanidipine is combined with Magnesium salicylate. |
Levothyroxine | The serum concentration of Levothyroxine can be decreased when it is combined with Magnesium salicylate. |
Lipoic Acid | Magnesium salicylate can cause a decrease in the absorption of Lipoic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Magnesium Sulfate | The risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Magnesium salicylate. |
Methotrexate | The serum concentration of Methotrexate can be increased when it is combined with Magnesium salicylate. |
Mycophenolic acid | The serum concentration of Mycophenolic acid can be decreased when it is combined with Magnesium salicylate. |
Nicardipine | The risk or severity of adverse effects can be increased when Nicardipine is combined with Magnesium salicylate. |
Nimodipine | The risk or severity of adverse effects can be increased when Nimodipine is combined with Magnesium salicylate. |
Nisoldipine | The risk or severity of adverse effects can be increased when Nisoldipine is combined with Magnesium salicylate. |
Nitrendipine | The risk or severity of adverse effects can be increased when Nitrendipine is combined with Magnesium salicylate. |
Oxytetracycline | Magnesium salicylate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Perhexiline | The risk or severity of adverse effects can be increased when Perhexiline is combined with Magnesium salicylate. |
Perindopril | Magnesium salicylate may decrease the antihypertensive activities of Perindopril. |
Phenindione | Magnesium salicylate may increase the anticoagulant activities of Phenindione. |
Phenprocoumon | Magnesium salicylate may increase the anticoagulant activities of Phenprocoumon. |
Pralatrexate | The serum concentration of Pralatrexate can be increased when it is combined with Magnesium salicylate. |
Prenylamine | The risk or severity of adverse effects can be increased when Prenylamine is combined with Magnesium salicylate. |
Probenecid | The therapeutic efficacy of Probenecid can be decreased when used in combination with Magnesium salicylate. |
Raltegravir | The serum concentration of Raltegravir can be decreased when it is combined with Magnesium salicylate. |
Reteplase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Reteplase. |
Ridogrel | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Ridogrel. |
Risedronate | The risk or severity of adverse effects can be increased when Risedronate is combined with Magnesium salicylate. |
Salicylate-sodium | Salicylate-sodium may increase the anticoagulant activities of Magnesium salicylate. |
Sparfloxacin | The serum concentration of Sparfloxacin can be decreased when it is combined with Magnesium salicylate. |
Streptokinase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Streptokinase. |
Sulodexide | Magnesium salicylate may increase the anticoagulant activities of Sulodexide. |
Tenecteplase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Tenecteplase. |
Torasemide | Magnesium salicylate may decrease the diuretic activities of Torasemide. |
Treprostinil | The risk or severity of adverse effects can be increased when Treprostinil is combined with Magnesium salicylate. |
Triethylenetetramine | The serum concentration of Magnesium salicylate can be decreased when it is combined with Triethylenetetramine. |
Urokinase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Urokinase. |
Valproic Acid | The serum concentration of Valproic Acid can be increased when it is combined with Magnesium salicylate. |
Verapamil | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium salicylate. |
Warfarin | Magnesium salicylate may increase the anticoagulant activities of Warfarin. |
Drug | Interaction |
---|---|
Abciximab | Magnesium salicylate may increase the anticoagulant activities of Abciximab. |
Acenocoumarol | Magnesium salicylate may increase the anticoagulant activities of Acenocoumarol. |
Acetazolamide | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Acetazolamide. |
Acetylsalicylic acid | Acetylsalicylic acid may increase the anticoagulant activities of Magnesium salicylate. |
Alfacalcidol | The serum concentration of Magnesium salicylate can be increased when it is combined with Alfacalcidol. |
Alteplase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Alteplase. |
Amlodipine | The risk or severity of adverse effects can be increased when Amlodipine is combined with Magnesium salicylate. |
Ammonium chloride | The serum concentration of Magnesium salicylate can be increased when it is combined with Ammonium chloride. |
Amrinone | The risk or severity of adverse effects can be increased when Amrinone is combined with Magnesium salicylate. |
Anistreplase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Anistreplase. |
Bepridil | The risk or severity of adverse effects can be increased when Bepridil is combined with Magnesium salicylate. |
Calcitriol | The serum concentration of Magnesium salicylate can be increased when it is combined with Calcitriol. |
Citric Acid | Magnesium salicylate may increase the anticoagulant activities of Citric Acid. |
Dalteparin | Magnesium salicylate may increase the anticoagulant activities of Dalteparin. |
Deferiprone | The serum concentration of Deferiprone can be decreased when it is combined with Magnesium salicylate. |
Desmopressin | The risk or severity of adverse effects can be increased when Desmopressin is combined with Magnesium salicylate. |
Dexketoprofen | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Dexketoprofen. |
Diclofenamide | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Diclofenamide. |
Dicoumarol | Magnesium salicylate may increase the anticoagulant activities of Dicoumarol. |
Dolutegravir | The serum concentration of Dolutegravir can be decreased when it is combined with Magnesium salicylate. |
Edetic Acid | Magnesium salicylate may increase the anticoagulant activities of Edetic Acid. |
Eltrombopag | The serum concentration of Eltrombopag can be decreased when it is combined with Magnesium salicylate. |
Enoxaparin | Magnesium salicylate may increase the anticoagulant activities of Enoxaparin. |
Ethoxzolamide | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Ethoxzolamide. |
Ethyl biscoumacetate | Magnesium salicylate may increase the anticoagulant activities of Ethyl biscoumacetate. |
Felodipine | The risk or severity of adverse effects can be increased when Felodipine is combined with Magnesium salicylate. |
Fludrocortisone | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Fludrocortisone. |
Flunarizine | The risk or severity of adverse effects can be increased when Flunarizine is combined with Magnesium salicylate. |
Fondaparinux sodium | Magnesium salicylate may increase the anticoagulant activities of Fondaparinux sodium. |
Gabapentin | Magnesium salicylate may increase the central nervous system depressant (CNS depressant) activities of Gabapentin. |
Ginkgo biloba | Ginkgo biloba may increase the anticoagulant activities of Magnesium salicylate. |
Heparin | Magnesium salicylate may increase the anticoagulant activities of Heparin. |
Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Magnesium salicylate. |
Insulin Regular | Magnesium salicylate may increase the hypoglycemic activities of Insulin Regular. |
Isradipine | The risk or severity of adverse effects can be increased when Isradipine is combined with Magnesium salicylate. |
Lamotrigine | The risk or severity of adverse effects can be increased when Lamotrigine is combined with Magnesium salicylate. |
Lercanidipine | The risk or severity of adverse effects can be increased when Lercanidipine is combined with Magnesium salicylate. |
Levothyroxine | The serum concentration of Levothyroxine can be decreased when it is combined with Magnesium salicylate. |
Lipoic Acid | Magnesium salicylate can cause a decrease in the absorption of Lipoic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Magnesium Sulfate | The risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Magnesium salicylate. |
Methotrexate | The serum concentration of Methotrexate can be increased when it is combined with Magnesium salicylate. |
Mycophenolic acid | The serum concentration of Mycophenolic acid can be decreased when it is combined with Magnesium salicylate. |
Nicardipine | The risk or severity of adverse effects can be increased when Nicardipine is combined with Magnesium salicylate. |
Nimodipine | The risk or severity of adverse effects can be increased when Nimodipine is combined with Magnesium salicylate. |
Nisoldipine | The risk or severity of adverse effects can be increased when Nisoldipine is combined with Magnesium salicylate. |
Nitrendipine | The risk or severity of adverse effects can be increased when Nitrendipine is combined with Magnesium salicylate. |
Oxytetracycline | Magnesium salicylate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Perhexiline | The risk or severity of adverse effects can be increased when Perhexiline is combined with Magnesium salicylate. |
Perindopril | Magnesium salicylate may decrease the antihypertensive activities of Perindopril. |
Phenindione | Magnesium salicylate may increase the anticoagulant activities of Phenindione. |
Phenprocoumon | Magnesium salicylate may increase the anticoagulant activities of Phenprocoumon. |
Pralatrexate | The serum concentration of Pralatrexate can be increased when it is combined with Magnesium salicylate. |
Prenylamine | The risk or severity of adverse effects can be increased when Prenylamine is combined with Magnesium salicylate. |
Probenecid | The therapeutic efficacy of Probenecid can be decreased when used in combination with Magnesium salicylate. |
Raltegravir | The serum concentration of Raltegravir can be decreased when it is combined with Magnesium salicylate. |
Reteplase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Reteplase. |
Ridogrel | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Ridogrel. |
Risedronate | The risk or severity of adverse effects can be increased when Risedronate is combined with Magnesium salicylate. |
Salicylate-sodium | Salicylate-sodium may increase the anticoagulant activities of Magnesium salicylate. |
Sparfloxacin | The serum concentration of Sparfloxacin can be decreased when it is combined with Magnesium salicylate. |
Streptokinase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Streptokinase. |
Sulodexide | Magnesium salicylate may increase the anticoagulant activities of Sulodexide. |
Tenecteplase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Tenecteplase. |
Torasemide | Magnesium salicylate may decrease the diuretic activities of Torasemide. |
Treprostinil | The risk or severity of adverse effects can be increased when Treprostinil is combined with Magnesium salicylate. |
Triethylenetetramine | The serum concentration of Magnesium salicylate can be decreased when it is combined with Triethylenetetramine. |
Urokinase | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Urokinase. |
Valproic Acid | The serum concentration of Valproic Acid can be increased when it is combined with Magnesium salicylate. |
Verapamil | The risk or severity of adverse effects can be increased when Verapamil is combined with Magnesium salicylate. |
Warfarin | Magnesium salicylate may increase the anticoagulant activities of Warfarin. |
Food Interactions:
- Not Available
Taxonomy
Super Class: Not Available
Class: Not Available
Sub Class: Not Available
Direct Parent: Not Available
Alternative Parents:
- Benzoic acids
- Benzoyl derivatives
- Carbonyl compounds
- Carboxylic acids
- Hydrocarbon derivatives
- Monocarboxylic acids and derivatives
- Organic salts
- Organic zwitterions
- Phenols and derivatives
- Vinylogous acids
substituent:
- Aromatic homomonocyclic compound
- Benzoic acid
- Benzoyl
- Carbonyl group
- Carboxylic acid
- Carboxylic acid derivative
- Hydrocarbon derivative
- Monocarboxylic acid or derivatives
- Organic salt
- Organic zwitterion
- Organooxygen compound
- Phenol
- Salicylic acid
- Vinylogous acid
References
General Reference: Not Available
External Links:
Resource | Link |
---|
Resource | Link |
---|
ATC Codes:
- Not Available
AHFS Codes:
- Not Available
MSDS: Download